Segantii Trial Enters Endgame as Defense Wraps Up Testimony

The insider trading trial of Segantii Capital Management came to a halt on Tuesday, following more than a month of testimony that put a magnifying glass on a tiny series of trades that took place almost a decade ago.

To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.